ArticleOncotarget2016

Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy.

Yun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.